Fed. Circ. Upholds Sanofi Win Over Generics In Multaq Suit
The Federal Circuit upheld a district court decision Thursday finding that two Sanofi patents for the heart rhythm medication Multaq were not invalid and that the generic versions of the drug...To view the full article, register now.
Already a subscriber? Click here to view full article